EUVIMEDEUVIMED entdecken
Crossref

Unveiling new thiazole‐clubbed piperazine derivatives as multitarget anti‐AD: Design, synthesis, and in silico studies

Eman E Nasr, Samar S Tawfik, Mohammed A M Massoud, Amany S Mostafa

Archiv der Pharmazie · 2024

DOI: 10.1002/ardp.202400044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, 2024. Verfasst von Eman E Nasr und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt. Hauptthemen laut MEDLINE: Alzheimer Disease, Drug Design, Cholinesterase Inhibitors, Molecular Docking Simulation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: None.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

New thiazole‐clubbed piperazine derivatives were designed, synthesized, evaluated for their inhibitory capabilities against human acetylcholinesterase and butyrylcholinesterase ( h AChE and/or h BuChE) and β‐amyloid (Aβ) aggregation, and investigated for their metal chelating potential as multitarget agents for the treatment of Alzheimer's disease. Compounds 10 , 19–21 , and 24 showed the highest h AChE inhibitory activity at submicromolar concentrations, of which compound 10 was the most potent with a half‐maximal inhibitory concentration (IC 50 ) value of 0.151 μM. Compounds 10 and 20 showed the best h BuChE inhibitory activities (IC 50 values of 0.135 and 0.103 μM, respectively), in addition to remarkable Aβ 1–42 aggregation inhibitory activities and metal chelating capabilities. Both compounds were further evaluated against human neuroblastoma SH‐SY5Y and PC12 neuronal cells, where they proved noncytotoxic at their active concentrations against h AChE or h BuChE. They also offered a significant neuroprotective effect against Aβ 25–35 ‐induced cytotoxicity in human neuroblastoma SH‐SY5Y cells. Compound 10 displayed acceptable physicochemical properties and could pass the blood–brain barrier. The molecular docking study revealed the good binding interactions of compound 10 with the key amino acids of both the catalytic active site and the peripheral anionic site of h AChE, explaining its significant potency.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseDrug DesignCholinesterase InhibitorsMolecular Docking SimulationThiazolesPiperazinesAmyloid beta-PeptidesAcetylcholinesteraseHumansStructure-Activity RelationshipRatsMolecular StructureAnimalsNeuroprotective AgentsPC12 CellsButyrylcholinesteraseDose-Response Relationship, DrugCell Line, TumorPeptide FragmentsComputer Simulation

Stichwörter der Autor:innen

ADAβhAChEpiperazinethiazole

Substanzen

Cholinesterase InhibitorsThiazolesPiperazinesAmyloid beta-PeptidesAcetylcholinesteraseNeuroprotective AgentsButyrylcholinesterasePeptide Fragmentsamyloid beta-protein (1-42)

Autor:innen und Institutionen

  • Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
  • Pharmacy Center of Scientific Excellence, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.

Förderung

  • None

Zitieren

APA

Nasr, E. E., Tawfik, S. S., Massoud, M. A. M., & Mostafa, A. S. (2024). Unveiling new thiazole‐clubbed piperazine derivatives as multitarget anti‐AD: Design, synthesis, and in silico studies. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202400044

Vancouver

Nasr EE, Tawfik SS, Massoud MAM, Mostafa AS. Unveiling new thiazole‐clubbed piperazine derivatives as multitarget anti‐AD: Design, synthesis, and in silico studies. Archiv der Pharmazie. 2024. doi:10.1002/ardp.202400044

BibTeX
@article{Nasr2024,
  author = {Nasr, Eman E and Tawfik, Samar S and Massoud, Mohammed A M and Mostafa, Amany S},
  title = {Unveiling new thiazole‐clubbed piperazine derivatives as multitarget anti‐AD: Design, synthesis, and in silico studies},
  journal = {Archiv der Pharmazie},
  year = {2024},
  doi = {10.1002/ardp.202400044}
}
Kostenlos starten →